(Q34270242)

English

Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE)

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE) (English)

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

van Doorn MB

5

1 reference

Europe PubMed Central

1 August 2017

Machielsen CS

7

1 reference

Europe PubMed Central

1 August 2017

S. J. de Visser

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

N. Uchida

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

E. van Vliet-Daskalopoulou

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

I. Fukazawa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

M. B A. van Doorn

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

M. W. van den Heuvel

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

C. S M. Machielsen

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

E. Uchida

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

A. F. Cohen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14561540

21 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14561540

21 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

1 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0010782403001409?httpAccept=text/xml

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

https://api.elsevier.com/content/article/PII:S0010782403001409?httpAccept=text/plain

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

1 reference

Europe PubMed Central

1 August 2017

68

1 reference

Europe PubMed Central

1 August 2017

3

1 reference

Europe PubMed Central

1 August 2017

195-202

1 reference

Europe PubMed Central

1 August 2017

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Protection against endometrial carcinoma by combination-product oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Risk factors for benign breast disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Incidence of endometrial cancer in relation to the use of oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Oral contraceptive health benefits: perception versus reality

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

A cohort study of oral contraceptive use and risk of benign breast disease

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Ovarian function during and after treatment with the new progestagen Org 30659.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Pharmacokinetics of ethynyloestradiol in women from different populations

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Variability of pharmacokinetic parameters for contraceptive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Plasma levels and pharmacokinetics of ethynyl estrogens in various populations. I. Ethynylestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Glucuronidation in humans. Pharmacogenetic and developmental aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Pharmacokinetics of ethinyl estradiol and mestranol

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Chromatographic patterns of urinary ethynyl estrogen metabolites in various populations

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Excretion balance and metabolism of the progestagen Org 30659 in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2803%2900140-9

7 January 2021

Effect on hypertension and benign breast disease of progestagen component in combined oral contraceptives

5

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

Oral contraceptives and epithelial ovarian cancer. Does dose matter?

10

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

Evolution of progestins. Focus on the novel progestin drospirenone

12

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3

20

1 reference

10.1016/S0010-7824(03)00140-9

https://api.crossref.org/works/10.1016/S0010-7824(03)00140-9

21 March 2024

Identifiers

10.1016/S0010-7824(03)00140-9

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34270242&oldid=2143680613"